NEPH News | Roxom Stocks

1 BTC

=

- USD

Loading market data...

NE

Mkt Cap

$39.6M

Volume

39.00K

Next Earnings

November 5th

Chart Financials Earnings News About Insider Filings

Nephros to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:00 a.m. ETNephros, Inc. (Nasdaq: NEPH), a water technology and filtration solutions company, announced that its President and CEO Robert Banks will present at Maxim Group LLC's virtual 'Health, Wellness & Longevity' conference on July 22, 2026, at 10:00 a.m. ET. The conference brings together leaders from companies innovating in beverages, food, supplements, and longevity sectors to discuss consumer preferences and emerging trends.GlobeNewswire Inc. · Jul 20, 2026

Nephros to Host Virtual Investor Event: “Beyond Filtration: The Nephros Model in Action”Nephros, Inc. announced a virtual investor event scheduled for July 16, 2026, titled 'Beyond Filtration: The Nephros Model in Action.' The event will showcase the company's differentiated approach to water safety beyond filtration products, featuring insights from field leaders, the Nephros Water Institute, and company leadership. The program will discuss growth opportunities, strategic priorities, and include a Q&A session.GlobeNewswire Inc. · Jun 18, 2026

Nephros Positions Ultrafiltration Technology as a Solution to Emerging Microplastic Risk in WaterNephros, Inc. announced that its ultrafiltration technology can effectively capture microplastics and nanoplastics from drinking water, positioning the company to address emerging water quality concerns. The announcement follows the U.S. EPA's April 2026 decision to include microplastics as a priority contaminant group under the Safe Drinking Water Act's draft Contaminant Candidate List (CCL 6). Nephros' filters feature pore sizes as small as 5 nanometers, enabling removal of particles smaller than conventional filtration technologies can address.GlobeNewswire Inc. · Jun 16, 2026

Nephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning ExpertiseNephros, Inc. announced an expansion of its water safety support capabilities following Director of Business Development Brianne McGuire's ASSE 12080 Legionella Water Safety and Management Specialist Certification. The company now offers Water Management Program (WMP) development services to healthcare facilities and complex buildings, creating a new revenue stream through chargeable consulting services while strengthening its value proposition in waterborne pathogen risk reduction.GlobeNewswire Inc. · Apr 1, 2026

Nephros Launches the Nephros Water Institute to Lead National Water Safety EducationNephros Inc. launched the Nephros Water Institute to provide educational resources on water safety, targeting professionals across healthcare and related sectors through webinars, speaking engagements, and tailored training programs.GlobeNewswire Inc. · Dec 11, 2025

Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial ResultsFull-Year Net Revenue of $14.2 Million and Fourth-Quarter Net Revenue of $3.3 MillionGlobeNewswire Inc. · Mar 7, 2024

Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial ResultsSOUTH ORANGE, NJ, Feb. 29, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its fourth quarter and fiscal year financial results on Thursday March 7, 2024 after market close and will host a conference call that same day at 4:30pm ET.GlobeNewswire Inc. · Feb 29, 2024

Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionShares of Despegar.com, Corp. (NYSE: DESP) rose sharply during Wednesday’s session after the company raised its FY23 financial guidance. The company said it now sees revenue of $690 million to $700 million, versus previous forecast of $670 million to $700 million. Despegar.com shares gained 16.4% to $9.90 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers Shattuck Labs, Inc. (NASDAQ: STTK) jumped 127.5% to $4.80 after the company announced initial topline dose-expansion data from its ongoing Phase 1A/B clinical trial of SL-172154 in combination with AZA in frontline HR-MDS and TP53m AML patients. ReShape Lifesciences Inc. (NASDAQ: RSLS) shares gained 63.8% to $0.4110 after the company announced it received FDA PMA supplement approval for its next-generation Lap-Band 2.0 FLEX. C4 Therapeutics, Inc. (NASDAQ: CCCC) shares jumped 59% to $3.7199 after the company announced data from the CFT7455 Phase 1 trial in relapsed/refractory multiple myeloma. Following the update, Stifel analyst Bradley Canino upgraded C4 Therapeutics from Hold to Buy and raised the price target from $2 to $12. RiskOn International, Inc. (NASDAQ: ROI) shares gained 38.3% to $0.2016 after declining 9% on Tuesday. Innovative International Acquisition Corp. (NASDAQ: IOAC) shares rose 36% to $11.66. NextPlay Technologies, Inc. (NASDAQ: NXTP) shares gained 26% to $1.1708 after surging 29% on Tuesday. Nephros, Inc. (NASDAQ: NEPH) rose 23% to $3.16. SciSparc Ltd. (NASDAQ: SPRC) gained 21.7% to $5.95 after the company announced results for MitoCareX Bio with its drug discovery platform. Eos Energy Enterprises, ...Benzinga · Dec 13, 2023

Insiders Buying Delcath Systems And 3 Other Penny StocksThe Dow Jones index closed higher by over 150 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Nephros The Trade: Nephros, Inc. (NASDAQ: NEPH) Director, President and CEO Robert R. Banks Jr. acquired a total of 18,000 shares an average price of $2.20. To acquire these shares, it cost around $39,647. What’s Happening: On Nov. 8, Nephros posted better-than-expected quarterly results. What ...Benzinga · Dec 12, 2023

Nephros Announces Results for Quarter Ended September 30, 2023Third-Quarter Net Revenue of $3.7 Million, a 55% Increase Over 2022; Net Loss from Continuing Operations Narrows 85% to $0.2 Million; $1.1 Million in Positive Year-to-Date Net Cash Flows from Operating ActivitiesGlobeNewswire Inc. · Nov 8, 2023

NE

NEPHNephros Inc.

NEPH

Pay with—

Available Balance0.00

Your PositionYou don't own any NEPH yet.

Related Tickers

Earnings